Dragon Pharma GW501516: The Drug That Rewired Muscle Metabolism — Then Vanished Over Cancer Rat Data

Dragon Pharma GW501516 supplies pharmaceutical-grade cardarine at 10 mg per oral capsule, packed sixty capsules per box for one month of standard intermediate dosing. Synthesized collaboratively by Ligand Pharmaceuticals and GlaxoSmithKline during the late 1990s, this PPARδ agonist never reached market approval precisely because its performance-enhancing properties proved inseparable from troubling toxicology signals discovered years later. What makes GW501516 pharmacologically remarkable involves gene-level reprogramming of skeletal muscle fiber behavior: activated PPARδ receptors force slow-twitch oxidative characteristics onto previously glycolytic tissue, flipping substrate preference from glycogen toward circulating fatty acids. Because no androgen receptor interaction occurs anywhere along that cascade, users gain endurance adaptations completely free of hormonal suppression — a distinction separating it fundamentally from every true SARM sold beside it.

How GW501516 Works

To begin with, cardarine functions as a high-affinity synthetic ligand for peroxisome proliferator-activated receptor delta, a nuclear transcription factor governing energy expenditure programs across muscle, adipose and liver tissue simultaneously. Once bound, PPARδ recruits coactivators that switch on hundreds of genes responsible for mitochondrial biogenesis, fatty-acid transport and oxidative phosphorylation efficiency.

Moreover, animal research demonstrated that merely activating this single receptor produced measurable running-capacity increases exceeding thirty percent in sedentary rodents — effects so dramatic they earned the nickname “exercise-in-a-pill” throughout pharmacology circles. It is worth noting that these adaptations accumulate gradually over weeks of consistent dosing paired with actual training stimulus, since untrained individuals still require mechanical loading to translate genetic signaling into observable stamina gains.

Product Specifications

• Active substance: GW501516 (cardarine / GSK-516)
• Strength: 10 mg per capsule
• Packaging: 60 capsules (600 mg total)
• Administration: Oral, split morning and evening doses
• Serum half-life: ~16–24 hours
• Hormonal impact: None — zero androgen receptor activity
• Common protocol: 10–20 mg/day, 8 weeks maximum
• Primary uses: Endurance enhancement, fat oxidation, insulin sensitivity, cutting preservation

You can browse other metabolic agents including SR9009, MK-2866 and Ostarine on the homepage catalog, or read about the facility standards behind every GP-branded blister on our About Us page.

Dosing Framework and Cycle Length

Standard protocols deliver 10 mg twice daily, splitting around twelve-hour intervals to maintain stable plasma concentration given the moderate half-life. Regarding timing, taking doses away from heavy meals improves absorption consistency, though gastrointestinal upset remains uncommon even on empty stomachs.

In practice, eight weeks represents the widely accepted ceiling before diminishing returns outweigh accumulated unknown risk. Since PPARδ expression downregulates subtly under chronic stimulation, extended continuous use produces progressively weaker adaptation anyway. Furthermore, stacking with resistance-training cycles preserves lean mass during aggressive deficits better than diet alone, which explains why cutting-phase athletes favor this compound most heavily.

The Carcinogenicity Question You Cannot Skip

First, understand exactly what happened: GSK terminated all clinical development in 2007 after two-year rodent bioassay data showed accelerated tumor formation across multiple organ systems — skin, liver, tongue, stomach, lungs and esophagus — at doses producing plasma exposures estimated near twenty-fold above intended human therapeutic levels. Second, independent researchers have since argued that absolute dose translation matters enormously, pointing out that typical athletic intake falls far below those tumorigenic thresholds, yet definitive long-term safety evidence simply does not exist because no follow-up human trials were ever permitted.

Consequently, anyone choosing to run GW501516 accepts genuine uncertainty regarding lifetime cancer risk, particularly relevant given WADA’s permanent prohibition since 2009. Nevertheless, short-duration low-dose exposure carries no confirmed human harm reports to date, leaving risk assessment honestly unresolved rather than settled either direction.

Where GW501516 Fits in a Stack

In practice, Dragon Pharma GW501516 slots naturally into recomp and cutting phases where preserving work capacity matters more than raw strength spikes. Conversely, pure bulking blocks rarely benefit meaningfully since caloric surplus already supports training volume without metabolic reprogramming. Explore compatible ancillaries including cardiovascular support and liver protectants on the ancillaries category.

Authenticity: Verify Before You Swallow

Research-chemical markets rank among the least regulated supply chains globally, with analyses repeatedly finding mislabeled potency, substituted actives or inert filler sold as cardarine. To eliminate that risk, Geneza Pharmaceuticals manufactures GP-branded products directly and never licenses the brand to resellers or co-packers. Every production run carries a unique alphanumeric batch number, a holographic seal, and a QR code resolving only to official domains.

Before opening the blister, enter those details on the Product Verification page. Missing, damaged, or altered security features signal a fake. Likewise, prices far below market average rank among the clearest red flags documented on that guide.

Storage, Handling, and Shipping

Store capsules between 20–25 °C away from humidity and direct sunlight; bathroom cabinets accelerate gelatin shell degradation precisely where steam collects nightly. Keep capsules sealed in the original blister until verification completes. Orders travel in plain, unmarked packaging with tracking available on request. If quantity limits or dispatch timelines concern you, message us through the contact page before ordering.

Final Word on GW501516

To summarize, few compounds illustrate the gap between mechanistic elegance and regulatory abandonment better than cardarine — one molecule rewriting muscle fuel preference without touching hormones, then shelved permanently over rodent oncology data whose relevance to human athletic dosing remains genuinely debated. Provided you cap cycles at eight weeks, keep daily intake conservative, accept unresolved long-term risk consciously and pair dosing with real training stimulus, GW501516 delivers endurance adaptations nothing else replicates cleanly. Buy direct to secure tested potency, documented batch provenance, and manufacturer accountability. Review related products on the official store, check recurring questions in the FAQ, learn who produces your capsules via About Us, confirm your specific batch through Product Verification, or reach a specialist directly at Contact.

Disclaimer: This description provides information only and does not constitute medical advice. GW501516 was never approved for human consumption, is prohibited by WADA and all major sporting bodies, and carries unresolved carcinogenicity concerns from preclinical data. Consult a qualified physician before considering use.